Navigation Links
Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd
Date:5/17/2013

MIAMI LAKES, Fla., May 17, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, announced today that it will hold a business update teleconference and webcast for shareholders and the investment community on Wednesday, May 22nd, 2013 at 4:30 PM ET.

Fuse Science, Inc. CEO, Brian Tuffin will host the call and will be joined by Rubin Hanan , President and COO and Jeanne Hebert , VP of Marketing and Clinical Research.  Among the topics the Fuse executives will discuss include; distribution channel progress, third quarter sales growth and marketing updates, and an overview of current developments with the company's science applications.Interested parties can listen to the live teleconference by dialing (877) 407-0782 from the U.S. or (201) 689-8567 for international callers.  Individuals may access the live audio webcast by visiting http://www.investorcalendar.com/IC/CEPage.asp?ID=171023.

A replay of the teleconference will be available until June 5, 2013 which can be accessed by dialing (877) 660-6853 if calling within the United States or (201) 612-7415, if calling internationally.  Please enter conference ID # 415071 to access the replay.  A replay of the webcast will also be archived and available within the investor relations section of the company's web site at www.fusescience.com.

About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).For more information:

To schedule an interview:Fuse Science, Inc.

Gus DeQuesadaInvestor Relations

Michelsen AdvertisingDirect: (305) 503-3873, Ext. 2

C-305-733-1410 / 786-488-7138Email: ir@fusescience.com

prnews@michelsenadvertising.com


'/>"/>
SOURCE Fuse Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fuse Science, Inc. DROPS Now Available at PoweredByFuse.com
2. Fuse Science, Inc. adds Major General Robert Dickerson (Ret.) to its Advisory Board
3. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
4. In basic science, sometimes it takes individual benefactors like Roys Poyiadjis to fuel innovation
5. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
6. IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business Unit
7. AVTs Customer Medbox, Inc. Featured in Bloomberg Businessweek
8. Bayer Employee Named Rising Star by Healthcare Businesswomens Association
9. Shelia Barchuk Named a VIP Member of Worldwide Whos Who for Excellence in Business Management
10. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
11. Virogens New Business Unit, "The Cannabis Connection," to Focus on High-End Medicinal Marijuana Dispensary Niche within $15-20 Billion Legal Marijuana Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... March 24, 2017 ShangPharma, a ... and cost-effective drug development and discovery services, ... biotechnology industry, announced today the intent for ... will be consolidating the Contract Research Organizations ... Shanghai ChemPartner. These entities include ChemPartner Shanghai, ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... to prep patients for colonoscopy at the HyGIeaCare® Center that is to be ... FL. , The HyGIeaCare® Prep, cleared by the U.S. Food and ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... ... Time GPS”: a dauntless and enlightened study of the second-coming of Christ, and ... published author, Wesley Gerboth, a World War II veteran, with a highly-regarded reputation as ... ninety-one, he shares the Wisdom God bestowed upon him in this publication. , ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... of inspiring stories about real people of God in congregations across the United ... Miller, a Presbyterian minister ordained in 1964 who has served congregations in seven ...
(Date:3/23/2017)... Greensboro, NC & Seattle, WA (PRWEB) , ... March 23, 2017 ... ... international public health emergency and now estimates that there could be four million Zika-related ... fastest growing epidemics to date with numbers of US cases reported per year skyrocketing ...
Breaking Medicine News(10 mins):